| http://www.w3.org/ns/prov#value | - Along with the regulatory approvals we have recently obtained from the FDA, Europe and other regulatory bodies, securing a promising late-stage client is a key component towards full commercialization of our product.We plan to make MicronJet a valuable component of our product offerings, as it provides consistent and easy to use delivery to our target location, the skin.
|
